Tweet
Cardiol Rev
. 2021 Mar 19.
doi: 10.1097/CRD.0000000000000385. Online ahead of print.
CARDIOVASCULAR AND CEREBROVASCULAR COMPLICATIONS WITH COVID-19
Arielle Greenberg 1 , Gayatri Pemmasani, Srikanth Yandrapalli, William H Frishman
Affiliations
- PMID: 33758123
- DOI: 10.1097/CRD.0000000000000385
Abstract
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) has impacted the health of people across the globe. Cardiovascular diseases (CVD) have a significant relationship with COVID-19, both as a risk factor and prognostic indicator, and as a complication of the disease itself. In addition to predisposing to CVD complications, the ongoing pandemic has severely affected the delivery of timely and appropriate care for cardiovascular conditions resulting in increased mortality. The etiology behind the cardiac injury associated with SARS-CoV-2 is likely varied, including coronary artery disease, microvascular thrombosis, myocarditis, stress cardiomyopathy. Further large-scale investigations are needed to better determine the underlying mechanism of myocardial infarction and other cardiac injury in COVID-19 patients, and to determine the incidence of each type of cardiac injury in this patient population. Telemedicine and remote monitoring technologies can play an important role in optimizing outcomes in patients with established CVD. In this article, we summarize the various impacts that COVID-19 has on the cardiovascular system, including myocardial infarction, myocarditis, stress cardiomyopathy, thrombosis and stroke.